Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Alcindor

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
BMJ Open Quality|March 9, 2021
Reasons for delay in timely administration of adjuvant chemotherapy for patients with stage III colon cancer: a multicentre cohort study from the McGill University Department of OncologyArielle Elkrief, Genevieve Redstone, Luca Petruccelli, et al.
Annals of Surgical Oncology|December 23, 2023
Docetaxel-Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15-Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer NetworkJames Tankel, Nabeel Ahmed, Carmen Mueller, et al.
Clinical Orthopaedics and Related Research|August 24, 2022
Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVENJohn H Healey, William D Tap, Heather L Gelhorn, et al.
Acta Orthopaedica|May 12, 2021
Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trialMichiel Van De Sande, William D Tap, Heather L Gelhorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi TrialRavin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2026
Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid TumorsRavin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Cancer Medicine|September 19, 2023
Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) studyHagit Peretz Soroka, Tushar Vora, Jonathan Noujaim, et al.
Clinical Colorectal Cancer|April 15, 2018
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group TrialDerek J Jonker, Patricia A Tang, Hagen Kennecke, et al.
Cancer|October 16, 2013
Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trialJolie Ringash, Heather-Jane Au, Lillian L Siu, et al.
The Oncologist|June 24, 2018
Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO)Loïc Chaigneau, Anna Patrikidou, Isabelle Ray-Coquard, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
BMJ Open Quality|March 9, 2021
Reasons for delay in timely administration of adjuvant chemotherapy for patients with stage III colon cancer: a multicentre cohort study from the McGill University Department of OncologyArielle Elkrief, Genevieve Redstone, Luca Petruccelli, et al.
Annals of Surgical Oncology|December 23, 2023
Docetaxel-Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15-Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer NetworkJames Tankel, Nabeel Ahmed, Carmen Mueller, et al.
Clinical Orthopaedics and Related Research|August 24, 2022
Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVENJohn H Healey, William D Tap, Heather L Gelhorn, et al.
Acta Orthopaedica|May 12, 2021
Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trialMichiel Van De Sande, William D Tap, Heather L Gelhorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi TrialRavin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2026
Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid TumorsRavin Ratan, Bernd Kasper, Thierry Alcindor, et al.
Cancer Medicine|September 19, 2023
Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) studyHagit Peretz Soroka, Tushar Vora, Jonathan Noujaim, et al.
Clinical Colorectal Cancer|April 15, 2018
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group TrialDerek J Jonker, Patricia A Tang, Hagen Kennecke, et al.
Cancer|October 16, 2013
Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trialJolie Ringash, Heather-Jane Au, Lillian L Siu, et al.
The Oncologist|June 24, 2018
Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO)Loïc Chaigneau, Anna Patrikidou, Isabelle Ray-Coquard, et al.
Pageof 7